Corneal sub-basal neural damage pattern in multiple myeloma patients treated with bortezomib: an in vivo confocal study.
a Division of Hematology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Federica
F
Cocito
b Division of Ophthalmology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Gabriella
G
Ricciardelli
a Division of Hematology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Silvia
S
Mangiacavalli
a Division of Hematology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Alessandra
A
Pompa
a Division of Hematology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Lara
L
Pochintesta
a Division of Hematology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Virginia
V
Ferretti
b Division of Ophthalmology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Roberto
R
Ceccuzzi
a Division of Hematology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Mario
M
Cazzola
b Division of Ophthalmology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Paolo Emilio
PE
Bianchi
a Division of Hematology, IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Alessandro
A
Corso
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib / Q000009:adverse effects* / Q000627:therapeutic use; D003316:Corneal Diseases / Q000175:diagnosis* / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D018613:Microscopy, Confocal / Q000379:methods; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D010523:Peripheral Nervous System Diseases / Q000175:diagnosis* / Q000209:etiology*
D000970:Antineoplastic Agents; D000069286:Bortezomib